Helius Reconciled Depreciation from 2010 to 2024

HSDT Stock  USD 0.49  0.03  6.52%   
Helius Medical Reconciled Depreciation yearly trend continues to be comparatively stable with very little volatility. Reconciled Depreciation is likely to outpace its year average in 2024. From the period from 2010 to 2024, Helius Medical Reconciled Depreciation quarterly data regression had r-value of  0.71 and coefficient of variation of  119.22. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2017-12-31
Previous Quarter
16 K
Current Value
16 K
Quarterly Volatility
51.9 K
 
Covid
Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Interest Expense of 244.2 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.21, Dividend Yield of 0.0 or PTB Ratio of 2.18. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
  
Check out the analysis of Helius Medical Correlation against competitors.

Latest Helius Medical's Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of Helius Medical Technologies over the last few years. It is Helius Medical's Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

Helius Reconciled Depreciation Regression Statistics

Arithmetic Mean114,776
Geometric Mean53,142
Coefficient Of Variation119.22
Mean Deviation111,731
Median17,000
Standard Deviation136,839
Sample Variance18.7B
Range465K
R-Value0.71
Mean Square Error10B
R-Squared0.51
Significance0
Slope21,770
Total Sum of Squares262.1B

Helius Reconciled Depreciation History

2024217.6 K
2023181 K
2022255 K
2021200 K
2020482 K
2019191 K
201859 K

About Helius Medical Financial Statements

Helius Medical shareholders use historical fundamental indicators, such as Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Helius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Reconciled Depreciation181 K217.6 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.